WallStreetZen

NASDAQ: MRNA
Moderna Inc Earnings & Revenue

MRNA past revenue growth

How has MRNA's revenue growth performed historically?
Company
6,516.01%
Industry
951.81%
Market
46.25%
MRNA's revenue has grown faster (712.68% per year) than the US Biotechnology industry average (141.1%)
Performance
MRNA's revenue has grown faster (712.68% per year) than the US market average (19.19%)
Performance

MRNA earnings and revenue history

Current Revenue
$7.0B
Current Earnings
$3.5B
Current Profit Margin
49.8%

MRNA Return on equity

Current Company
88.1%
Current Industry
1.7%
Current Market
32.8%
MRNA's Return on Equity (88.1%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

MRNA Return on assets

Current Company
34.2%
Current Industry
-7.9%
Current Market
7.7%
MRNA is generating higher Return on Assets (34.2%) than the US Biotechnology industry average (-4.15%)
Performance

MRNA Return on capital employed

Current Company
52.23%
Current Industry
1.5%

MRNA earnings dates

Next earnings date
Oct 27, 2021

Moderna Earnings & Revenue FAQ

What were MRNA's earnings last quarter?

On Invalid Date, Moderna (NASDAQ: MRNA) reported Q2 2021 earnings per share (EPS) of $6.93, up 2,335.48% year over year. Total Moderna earnings for the quarter were $2.78 billion. In the same quarter last year, Moderna's earnings per share (EPS) was -$0.31.

What was MRNA's earnings growth in the past year?

As of Q3 2021, Moderna's earnings has grown null year over year. Moderna's earnings in the past year totalled $3.49 billion.

What is MRNA's earnings date?

Moderna's earnings date is Invalid Date. Add MRNA to your watchlist to be reminded of MRNA's next earnings announcement.

What was MRNA's revenue last quarter?

On Invalid Date, Moderna (NASDAQ: MRNA) reported Q2 2021 revenue of $4.35 billion up 6,398.51% year over year. In the same quarter last year, Moderna's revenue was $67.00 million.

What was MRNA's revenue growth in the past year?

As of Q3 2021, Moderna's revenue has grown 6,516.01% year over year. This is 5,564.21 percentage points higher than the US Biotechnology industry revenue growth rate of 951.81%. Moderna's revenue in the past year totalled $7.02 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.